Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain
- PMID: 3115992
Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain
Abstract
This study was undertaken to determine if apolipoprotein (apo) E-containing lipoproteins and their receptors could provide a system for lipid transport and cholesterol homeostasis in the brain, as they do in other tissues. To accomplish this goal, the lipoproteins in human and canine cerebrospinal fluid (CSF) were characterized, and rat brain and monkey brain were examined for the presence of apoB,E(LDL) receptors. Apolipoprotein E and apoA-I were present in human and canine CSF, but apoB could not be detected. Apo-lipoprotein E and apoA-I were both present on lipoproteins with a density of approximately 1.09 to 1.15 g/ml. In human CSF, the lipoproteins were primarily spherical (approximately 140 A), whereas in canine CSF the lipoproteins were a mixture of discs (200 x 65 A) and spheres (approximately 130 A). Apolipoproteins E and A-I were contained primarily in separate populations of lipoproteins. Although the apoE of CSF was more highly sialylated than plasma apoE, the apoE-containing lipoproteins in canine CSF competed as effectively as canine plasma apoE HDLc for binding of 125I-LDL to the apoB,E(LDL) receptors on human fibroblasts. The presence of apoB,E(LDL) receptors in both rat and monkey brain was demonstrated by immunocytochemistry. Astrocytes abutting on the arachnoid space and pial cells of the arachnoid itself, both of which contact CSF, expressed apoB,E(LDL) receptors. Relatively few receptors were present in the cells of the gray matter of the cortex. Receptors were more prominent on the astrocytes of white matter and in the cells of the brain stem. The expression of apoB,E(LDL) receptors by brain cells and the presence of apoE- and apoA-I-containing lipoproteins in CSF suggest that the central nervous system has a mechanism for lipid transport and cholesterol homeostasis similar to that of other tissues.
Similar articles
-
Remodelling of cerebrospinal fluid lipoproteins after subarachnoid hemorrhage.Atherosclerosis. 2003 Sep;170(1):141-6. doi: 10.1016/s0021-9150(03)00249-1. Atherosclerosis. 2003. PMID: 12957692
-
Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes.Exp Neurol. 1998 Jan;149(1):175-82. doi: 10.1006/exnr.1997.6710. Exp Neurol. 1998. PMID: 9454626
-
Characterization of four lipoprotein classes in human cerebrospinal fluid.J Lipid Res. 2001 Jul;42(7):1143-51. J Lipid Res. 2001. PMID: 11441143
-
Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1567-70. doi: 10.1161/hq1001.097780. Arterioscler Thromb Vasc Biol. 2001. PMID: 11597927 Review.
-
Brain lipoprotein metabolism and its relation to neurodegenerative disease.Crit Rev Neurobiol. 1999;13(4):357-407. doi: 10.1615/critrevneurobiol.v13.i4.20. Crit Rev Neurobiol. 1999. PMID: 11028681 Review.
Cited by
-
Transcriptome Analyses in BV2 Microglial Cells Following Treatment With Amino-Terminal Fragments of Apolipoprotein E.Front Aging Neurosci. 2020 Aug 13;12:256. doi: 10.3389/fnagi.2020.00256. eCollection 2020. Front Aging Neurosci. 2020. PMID: 32922284 Free PMC article.
-
Role of endolysosomes and cholesterol in the pathogenesis of Alzheimer's disease: Insights into why statins might not provide clinical benefit.Austin J Pharmacol Ther. 2014 Aug 26;2(6):1035. Austin J Pharmacol Ther. 2014. PMID: 25859562 Free PMC article.
-
A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve.J Clin Invest. 1989 Mar;83(3):1015-31. doi: 10.1172/JCI113943. J Clin Invest. 1989. PMID: 2493483 Free PMC article.
-
Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer's disease: A genetic and proteomic multi-cohort study.PLoS One. 2019 Aug 22;14(8):e0220254. doi: 10.1371/journal.pone.0220254. eCollection 2019. PLoS One. 2019. PMID: 31437157 Free PMC article.
-
Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.Neurochem Res. 2007 Apr-May;32(4-5):555-67. doi: 10.1007/s11064-006-9125-8. Epub 2006 Aug 17. Neurochem Res. 2007. PMID: 16915364 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous